ctrl K

Advertisement

Silverback Therapeutics I... (SBTX)

NASDAQ: SBTX · Real-Time Price · USD

5.87

0.06 (1.03%)

At close: Nov 09, 2022, 5:00 AM

Silverback Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018
Revenue	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	n/a	n/a	n/a	n/a
Gross Profit	n/a	n/a	n/a	n/a	n/a
Operating Income	-35.52M	-89.37M	-32.92M	-24.07M	-18.32M
Interest Income	n/a	n/a	-29K	100K	43K
Pretax Income	-34.68M	-89.48M	-32.95M	-23.97M	-17.58M
Net Income	-33.85M	-89.58M	-32.95M	-23.97M	-17.58M
Selling & General & Admin	18.46M	28.08M	8.34M	2.56M	3.52M
Research & Development	18.38M	61.5M	24.58M	21.5M	14.8M
Other Expenses	n/a	n/a	n/a	n/a	n/a
Operating Expenses	36.83M	89.58M	32.92M	24.07M	18.32M
Interest Expense	-834K	106K	-29K	n/a	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	36.83M	89.58M	32.92M	24.07M	18.32M
Income Tax Expense	-834K	106K	-29K	100K	741K
Shares Outstanding (Basic)	39.96M	2.91M	2.91M	4.89M	4.89M
Shares Outstanding (Diluted)	39.96M	2.91M	2.91M	4.89M	4.89M
EPS (Basic)	-0.85	-30.81	-11.33	-4.9	-3.59
EPS (Diluted)	-0.85	-30.81	-11.33	-4.9	-3.59
EBITDA	-35.52M	-88.59M	-32.31M	-23.42M	-17.1M
EBIT	n/a	-89.37M	-32.98M	n/a	n/a
Depreciation & Amortization	319K	783K	637K	544K	480K